Rubric Capital Management (New York)’s Strongbridge Biopharma plc. SBBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,072,732
Closed -$6.27M 86
2021
Q3
$6.27M Buy
3,072,732
+376,968
+14% +$877K 0.18% 48
2021
Q2
$8.01M Buy
+2,695,764
New +$7.12M 0.5% 43

Rubric Capital Management (New York)'s SBBP Position: Q4 2021 in Review

Rubric Capital Management (New York) sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 3,072,732 shares — an estimated $6.27M sold.

Rubric Capital Management (New York) first reported a position in SBBP in Q2 2021 and held it in 2 quarters. The position peaked at $8.01M in Q2 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

  • Rubric Capital Management (New York) reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 3,072,732 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $6.27M.
  • Rubric Capital Management (New York) first reported a position in Strongbridge Biopharma plc. in Q2 2021 and held it in 2 quarters.
  • Rubric Capital Management (New York)'s Strongbridge Biopharma plc. position peaked at $8.01M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.